Cargando…

Ubiquitin variants potently inhibit SARS-CoV-2 PLpro and viral replication via a novel site distal to the protease active site

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has made it clear that combating coronavirus outbreaks benefits from a combination of vaccines and therapeutics. A promising drug target common to all coronaviruses—including SARS-CoV, MERS-CoV, and SARS-CoV-2—is the papain-li...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Vliet, Vera J. E., Huynh, Nhan, Palà, Judith, Patel, Ankoor, Singer, Alex, Slater, Cole, Chung, Jacky, van Huizen, Mariska, Teyra, Joan, Miersch, Shane, Luu, Gia-Khanh, Ye, Wei, Sharma, Nitin, Ganaie, Safder S., Russell, Raquel, Chen, Chao, Maynard, Mindy, Amarasinghe, Gaya K., Mark, Brian L., Kikkert, Marjolein, Sidhu, Sachdev S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822107/ https://www.ncbi.nlm.nih.gov/pubmed/36548304 http://dx.doi.org/10.1371/journal.ppat.1011065

Ejemplares similares

The Role of Atypical Ubiquitin Chains in the Regulation of the Antiviral Innate Immune Response
por: van Huizen, Mariska, et al.
Publicado: (2020)

Development of Monoclonal Antibodies to Detect for SARS-CoV-2 Proteins
por: Mishra, Nawneet, et al.
Publicado: (2022)

Monoclonal antibodies binding data for SARS-CoV-2 proteins
por: Mishra, Nawneet, et al.
Publicado: (2022)

Intracellular targeting with engineered proteins
por: Miersch, Shane, et al.
Publicado: (2016)

Ultrapotent and broad neutralization of SARS-CoV-2 variants by modular, tetravalent, bi-paratopic antibodies
por: Miersch, Shane, et al.
Publicado: (2022)

Recent Advances in Replication and Infection of Human Parvovirus B19
por: Ganaie, Safder S., et al.
Publicado: (2018)

Antigenic mapping reveals sites of vulnerability on α-HCoV spike protein
por: Xiang, Jiangchao, et al.
Publicado: (2022)

SARS-COV-2 Coronavirus Papain-like Protease PLpro as an Antiviral Target for Inhibitors of Active Site and Protein–Protein Interactions
por: Ershov, P. V., et al.
Publicado: (2023)

Inhibitors of SARS-CoV-2 PLpro
por: Calleja, Dale J., et al.
Publicado: (2022)

Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations
por: Miersch, Shane, et al.
Publicado: (2021)

SARS-CoV-2: the many pros of targeting PLpro
por: McClain, Christopher B., et al.
Publicado: (2020)

Editorial: Virus-induced innate immune response and inflammation
por: Ganaie, Safder S., et al.
Publicado: (2023)

Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2
por: Klemm, Theresa, et al.
Publicado: (2020)

The ubiquitin interacting motifs of USP37 act on the proximal Ub of a di-Ub chain to enhance catalytic efficiency
por: Manczyk, Noah, et al.
Publicado: (2019)

Identification of Doxorubicin as Repurposing Inhibitory Drug for MERS-CoV PLpro
por: Alaofi, Ahmed L., et al.
Publicado: (2022)

6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro
por: Swaim, Caleb D., et al.
Publicado: (2021)

Oropouche orthobunyavirus infection is mediated by the cellular host factor Lrp1
por: Schwarz, Madeline M., et al.
Publicado: (2022)

PERK interacts with FLNA to regulate ER-PM contact sites
por: van Vliet, Alexander R., et al.
Publicado: (2017)

Crimean-Congo hemorrhagic fever virus nucleocapsid protein has dual RNA binding modes
por: Jeeva, Subbiah, et al.
Publicado: (2017)

Phosphorylated STAT5 directly facilitates parvovirus B19 DNA replication in human erythroid progenitors through interaction with the MCM complex
por: Ganaie, Safder S., et al.
Publicado: (2017)

A systematic approach to identify novel cancer drug targets using machine learning, inhibitor design and high-throughput screening
por: Jeon, Jouhyun, et al.
Publicado: (2014)

6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro protease activities
por: Swaim, Caleb D., et al.
Publicado: (2020)

High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors
por: Zhao, Yao, et al.
Publicado: (2021)

Evaluating Stability and Activity of SARS-CoV-2 PLpro for High-throughput Screening of Inhibitors
por: Arya, Rimanshee, et al.
Publicado: (2021)

Phytocompounds as potential inhibitors of SARS-CoV-2 Mpro and PLpro through computational studies
por: Rudrapal, Mithun, et al.
Publicado: (2022)

Genetically Encoded Fluorescent Sensors for SARS-CoV-2 Papain-like Protease PLpro
por: Sokolinskaya, Elena L., et al.
Publicado: (2022)

Identification and characterization of aurintricarboxylic acid as a potential inhibitor of SARS-CoV-2 PLpro
por: Arya, Rimanshee, et al.
Publicado: (2023)

Rapid On-Site Pathology Visualization of COVID-19 Characteristics Using Higher Harmonic Generation Microscopy
por: van Huizen, Laura M. G., et al.
Publicado: (2023)

Lrp1 is essential for lethal Rift Valley fever hepatic disease in mice
por: Schwarz, Madeline M., et al.
Publicado: (2023)

Rift Valley Fever Virus Infects the Posterior Segment of the Eye and Induces Inflammation in a Rat Model of Ocular Disease
por: Schwarz, Madeline M., et al.
Publicado: (2022)

Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay
por: Narayanan, Anoop, et al.
Publicado: (2022)

Structure-based drug designing of naphthalene based SARS-CoV PLpro inhibitors for the treatment of COVID-19
por: Bhati, Shipra
Publicado: (2020)

Identification of SARS‐CoV‐2 Papain‐like Protease (PLpro) Inhibitors Using Combined Computational Approach
por: Sencanski, Milan, et al.
Publicado: (2022)

Methods for Enrichment and Assignment of N-Acetylglucosamine Modification Sites
por: Maynard, Jason C., et al.
Publicado: (2021)

Establishment of a Replicon Reporter of the Emerging Tick-Borne Bourbon Virus and Use It for Evaluation of Antivirals
por: Hao, Siyuan, et al.
Publicado: (2020)

Novel mutations in NSP-1 and PLPro of SARS-CoV-2 NIB-1 genome mount for effective therapeutics
por: Hossain, Mohammad Uzzal, et al.
Publicado: (2021)

Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro Inhibitors
por: Calleja, Dale J., et al.
Publicado: (2022)

Association between Mutations in Papain-like Protease (PLpro) of SARS-CoV-2 with COVID-19 Clinical Outcomes
por: Tan, Jinlin, et al.
Publicado: (2022)

Deciphering the Potential of Pre and Pro-Vitamin D of Mushrooms against Mpro and PLpro Proteases of COVID-19: An In Silico Approach
por: Tiwari, Abhay, et al.
Publicado: (2022)

Coronaviral PLpro proteases and the immunomodulatory roles of conjugated versus free Interferon Stimulated Gene product-15 (ISG15)
por: Gold, Inbar Magid, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qlvhion2kuem1b38qm3k7b762d